Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Feb 1 2001
The Honorable George W. BushPresident of the United StatesThe White House1600 Pennsylvania Avenue, NWWashington, DC 20500 Dear Mr. President: Recently certain...
Jan 30 2001
WASHINGTON, DC (January 30, 2001) –Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on President...
Jan 25 2001
WASHINGTON, D.C. (January 25, 2001) – The BiotechnologyIndustry Organization’s (BIO) CEO & Investor Conference next month in New York will showcase the...
Jan 17 2001
(Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today regarding a notice of an FDA proposed rule...
Jan 17 2001
WASHINGTON, D.C. (January 17, 2001) -- Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) issued the following statement on the U.S....
Jan 9 2001
BIO seeks strong role in Medicare debate WASHINGTON, D.C. (January 9, 2001) – The Biotechnology Industry Organization (BIO) today named Sharon L. Cohen BIO’s...
Jan 5 2001
WASHINGTON, D.C. (January 5, 2001) - Lila Feisee, director of intellectual property for the Biotechnology Industry Organization (BIO), issued the following...
Dec 22 2000
WASHINGTON, D.C. (December 22, 2000) - The Biotechnology Industry Organization (BIO) will host the third annual CEO & Investor Conference, "Investing...
Dec 18 2000
Lee Rawls, Chief of Staff to US Senator Bill Frist, Named BIO's new Vice President for Government Relations WASHINGTON, D.C. (December 18, 2000) – “I am...


Biotechnology News

August 21, 2014

OVERLAND PARK, Kan.--(BUSINESS WIRE)--New York mental health, alcoholism and substance abuse treatment providers get a partner in record standardization as Netsmart's...

August 21, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--Clinipace Worldwide, a global digital clinical research organization (dCRO), announced the company has been named to Inc. Magazine’s...

August 21, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Spero Therapeutics, LLC announces the publication of a paper in the journal PLoS Pathogens describing the first known compounds to...

August 21, 2014

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration...